|
|
DEXTROSE MONOHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
DIACETYLATED MONOGLYCERIDES Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
DIBASIC CALCIUM PHOSPHATE DIHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
DIMETHICONE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|